Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Deficiency of mannose-binding lectin is a risk of Pneumocystis jirovecii pneumonia in a natural history cohort of people living with HIV/AIDS in Northern Thailand.

Tytuł:
Deficiency of mannose-binding lectin is a risk of Pneumocystis jirovecii pneumonia in a natural history cohort of people living with HIV/AIDS in Northern Thailand.
Autorzy:
Yanagisawa K; Department of Hematology, Gunma University Hospital, Maebashi, Japan.; Infection Control and Prevention Center, Gunma University Hospital, Maebashi, Japan.
Wichukchinda N; Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
Tsuchiya N; Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Yasunami M; Department of Laboratory Medicine, Saga-Ken Medical Centre Koseikan, Saga, Japan.
Rojanawiwat A; Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
Tanaka H; HLA Foundation Laboratory, Kyoto, Japan.
Saji H; HLA Foundation Laboratory, Kyoto, Japan.
Ogawa Y; Department of Hematology, Gunma University Hospital, Maebashi, Japan.
Handa H; Department of Hematology, Gunma University Hospital, Maebashi, Japan.
Pathipvanich P; Day Care Centre, Lampang Hospital, Lampang, Thailand.
Ariyoshi K; Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Sawanpanyalert P; Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
Źródło:
PloS one [PLoS One] 2020 Dec 23; Vol. 15 (12), pp. e0242438. Date of Electronic Publication: 2020 Dec 23 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
AIDS-Related Opportunistic Infections/*epidemiology
Mannose-Binding Lectin/*deficiency
Pneumocystis carinii/*isolation & purification
Pneumonia, Pneumocystis/*epidemiology
AIDS-Related Opportunistic Infections/diagnosis ; AIDS-Related Opportunistic Infections/genetics ; AIDS-Related Opportunistic Infections/microbiology ; Adolescent ; Adult ; Female ; Follow-Up Studies ; Genetic Predisposition to Disease ; Genotyping Techniques ; Humans ; Immunity, Innate/genetics ; Incidence ; Male ; Mannose-Binding Lectin/genetics ; Mannose-Binding Lectin/immunology ; Middle Aged ; Pneumocystis carinii/immunology ; Pneumonia, Pneumocystis/diagnosis ; Pneumonia, Pneumocystis/genetics ; Pneumonia, Pneumocystis/microbiology ; Prospective Studies ; Risk Factors ; Thailand/epidemiology ; Young Adult
References:
Front Immunol. 2018 Jun 04;9:1261. (PMID: 29915598)
BMC Infect Dis. 2014 Oct 30;14:565. (PMID: 25361850)
J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):174-9. (PMID: 15671802)
Int J Infect Dis. 2010 Jun;14(6):e460-8. (PMID: 19828347)
J Med Assoc Thai. 2004 Aug;87(8):951-4. (PMID: 15471301)
Nat Rev Immunol. 2011 Apr;11(4):275-88. (PMID: 21394104)
Lancet Respir Med. 2013 May;1(3):224-32. (PMID: 24429128)
J Infect Chemother. 2015 Nov;21(11):769-75. (PMID: 26271591)
Clin Exp Immunol. 2006 Jul;145(1):173-82. (PMID: 16792688)
Clin Infect Dis. 2003 Dec 1;37(11):1496-505. (PMID: 14614673)
Nat Rev Microbiol. 2007 Apr;5(4):298-308. (PMID: 17363968)
Immunobiology. 2009;214(7):562-75. (PMID: 19261355)
J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):157-60. (PMID: 12571525)
Ann Intern Med. 1989 Aug 1;111(3):223-31. (PMID: 2546472)
AIDS. 2013 Apr 24;27(7):1179-84. (PMID: 23276810)
Int Health. 2011 Jun;3(2):101-7. (PMID: 24038182)
AIDS. 2019 Sep 1;33(11):1719-1727. (PMID: 31225812)
J Infect Dis. 2003 Jun 15;187 Suppl 2:S335-9. (PMID: 12792848)
Genes Immun. 2006 Mar;7(2):85-94. (PMID: 16395391)
Nat Commun. 2017 Sep 19;8(1):599. (PMID: 28928442)
Cell. 2016 Oct 20;167(3):643-656.e17. (PMID: 27768888)
Arch Intern Med. 1998 Mar 9;158(5):491-7. (PMID: 9508227)
J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):356-361. (PMID: 29528943)
Hum Immunol. 2008 Dec;69(12):877-84. (PMID: 18952132)
Antiviral Res. 2010 Jul;87(1):22-9. (PMID: 20382184)
EBioMedicine. 2017 Aug;22:155-163. (PMID: 28705464)
BMC Infect Dis. 2014 Apr 29;14:229. (PMID: 24775713)
J Infect Dis. 2011 Jun 1;203(11):1686-91. (PMID: 21592999)
Am J Respir Cell Mol Biol. 2000 Oct;23(4):452-9. (PMID: 11017909)
Am J Trop Med Hyg. 2017 Jul;97(1):49-56. (PMID: 28719295)
Am J Infect Control. 2000 Oct;28(5):365-9. (PMID: 11029136)
Epidemiol Infect. 2013 Sep;141(9):1840-8. (PMID: 23114262)
AIDS. 2015 Aug 24;29(13):1607-15. (PMID: 26372271)
Substance Nomenclature:
0 (MBL2 protein, human)
0 (Mannose-Binding Lectin)
Entry Date(s):
Date Created: 20201228 Date Completed: 20210119 Latest Revision: 20210119
Update Code:
20240105
PubMed Central ID:
PMC7757797
DOI:
10.1371/journal.pone.0242438
PMID:
33362211
Czasopismo naukowe
Background: Mannose-binding lectin (MBL) plays a pivotal role in innate immunity; however, its impact on susceptibility to opportunistic infections (OIs) has not yet been examined in a natural history cohort of people living with HIV/AIDS.
Methods: We used archived samples to analyze the association between MBL expression types and risk of major OIs including Pneumocystis jirovecii pneumonia (PCP), cryptococcosis, talaromycosis, toxoplasmosis, and tuberculosis in a prospective cohort in Northern Thailand conducted from 1 July 2000 to 15 October 2002 before the national antiretroviral treatment programme was launched.
Results: Of 632 patients, PCP was diagnosed in 96 (15.2%) patients, including 45 patients with new episodes during the follow-up period (1006.5 person-years). The total history of PCP was significantly associated with low MBL expression type: high/intermediate (81/587, 13.8%), low (10/33, 30.3%) and deficient (5/12, 41.7%) (p = 0.001), whereas the history of other OIs showed no relation with any MBL expression type. Kaplan-Meier analysis (n = 569; log-rank p = 0.011) and Cox's proportional hazards model revealed that deficient genotype dramatically increased the risk of PCP, which is independent upon sex, age, CD4 count, HIV-1 viral load and hepatitis B and C status (adjusted hazard ratio 7.93, 95% confidence interval 2.19-28.67, p = 0.002).
Conclusions: Deficiency of MBL expression is a strong risk factor determining the incidence of PCP but not other major OIs.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies